After Hours
There is a slight risk associated with trading before and after the market open. Due to lower liquidity and higher volatility, extended-hours trading may result in wider spreads on particular security due to the release of critical financial information after regular trading hours. After-hours trades for Adicet Bio Inc. (ACET) shows that investor sentiment remained broken, with the stock’s consolidated last price falling by -$0.02, or -1.00%, to $1.98. The Adicet Bio Inc. has recorded 7,841 volume in the after hours trading session. Most recently, Yahoo Finance reported about the stock as it publicized that Adicet Bio Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4).
Top 5 EV Tech Stocks to Buy for 2023
The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".
Click Here to Download the FREE Report.
Sponsored
Stocks Info
This NASDAQ-listed company operates within the Biotechnology industry segment, falling under the Healthcare sector. At the end of the last regular session, the stock closed at $2.00 and fluctuated between $2.0150 as its day high and $1.8100 as its day low. The current market capitalization of Adicet Bio Inc. is $90.30M. A total of 0.69 million shares were traded on the day, compared to an average of 939.80K shares.
Insider Activity
Insider trades can also provide insight into a stock’s future direction. During the recent three months, ACET has seen 16 BUY and 0 SELL insider trades, representing the acquisition of 1,796,300 and the disposition of 0 shares. Over the last 12 months, there were 27 BUYs and 25 SELLs from insiders. Insiders purchased 2,106,391 shares during that period but sold 375,298.
In the most recent transaction, DUBIN STEVE bought 5,000 shares of ACET for 2.40 per share on Jun 30. After the transaction, the Director now owns 10,900 company shares. In a previous transaction on Jun 27, GORDON CARL L bought 875,000 shares at 2.09 per share. ACET shares that Director owns now total 5,685,259.
Among the insiders who bought shares, ORBIMED ADVISORS LLC acquired of 875,000 shares on Jun 27 at a per-share price of $2.09. This resulted in the Director holding 5,685,259 shares of ACET after the transaction. In another insider transaction, Healey Don sold 4,533 shares at $7.57 per share on Feb 15. Company shares held by the Chief Technology Officer now total 66,568.
Dividend
The income generated by dividends is an indication that a company is improving its financial position, which is why investors prefer companies paying dividends. ACET’s most recent ex-dividend date was 9/21/2018 when it declared a $0.01 quarterly dividend that was paid in cash on 10/9/2018. Previously, the company paid the dividend on 6/22/2018 with an ex-dividend date of 6/7/2018. The ACET stock dividend was $0.01 per share in cash.
Even though price targets are rarely accurate, they do tend to exert some kind of influence from time to time and are often considered important by markets. According to analysts who have offered 12-month price targets for ACET in the last 3 months, the mean price target is $21.00 with high estimates of $28.00 and low estimates of $10.00. In terms of 52-week highs and lows, ACET has a high of $21.87 and a low of $1.62.
As of this writing, ACET has an earnings estimate of -$0.73 per share for the current quarter. EPS was calculated based on a consensus of 9 estimates, with a high estimate of -$0.44 per share and a lower estimate of -$0.83. The company reported an EPS of -$0.72 in the last quarter, which was -4.30% lower than expectations of -$0.69.
Balance Sheet Annually/Quarterly
In a balance sheet, you can see what assets and liabilities the company has, as well as how much equity investors have invested. These figures can be used to calculate a company’s financial ratios to give investors a better idea of its prospects. ACET’s latest balance sheet shows that the firm has $277.54M in Cash & Short Term Investments as of fiscal 2021. There were $20.94M in debt and $16.32M in liabilities at the time. Its Book Value Per Share was $5.57, while its Total Shareholder’s Equity was $303.13M.
Analysts Opinion
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for ACET is Buy with a score of 4.25.
